K080561

Substantially Equivalent

VIDAS CA 125 II ASSAY

Applicant: bioMerieux, Inc.
Product code: LTK
Advisory panel: Immunology
Date received: 2008-02-28
Decision date: 2009-04-10
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Hazelwood, MO, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.